Ara
Toplam kayıt 3, listelenen: 1-3
Geographical Variation In Therapy For Bloodstream Infections Due To Multidrug-Resistant Enterobacteriaceae: A Post-Hoc Analysis Of The Increment Study
(Elsevier Science Bv, 2017)
We describe regional differences in therapy for bloodstream infection (BSI) caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) or carbapenemase-producing Enterobacteriaceae (CPE). Patients (n ...
Development And Validation Of The Increment-Esbl Predictive Score For Mortality In Patients With Bloodstream Infections Due To Extendedspectrum- Beta-Lactamase-Producing Enterobacteriaceae
(Oxford Univ Press, 2017)
Background. Bloodstream infections (BSIs) due to ESBL-producing Enterobacteriaceae (ESBL-E) are frequent yet outcome prediction rules for clinical use have not been developed. The objective was to define and validate a ...
Empiric Therapy With Carbapenem-Sparing Regimens For Bloodstream Infections Due To Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae: Results From The Increment Cohort
(Oxford Univ Press, 2017)
Background. There is little information about the efficacy of active alternative drugs to carbapenems except beta-lactam/beta-lactamase inhibitors for the treatment of bloodstream infections (BSIs) due to extended-spectrum ...